Growth Metrics

Forte Biosciences (FBRX) Return on Assets (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Return on Assets for 4 consecutive years, with 2.08% as the latest value for Q3 2020.

  • On a quarterly basis, Return on Assets fell 177.0% to 2.08% in Q3 2020 year-over-year; TTM through Sep 2020 was 2.08%, a 177.0% decrease, with the full-year FY2019 number at 1.15%, down 65.0% from a year prior.
  • Return on Assets was 2.08% for Q3 2020 at Forte Biosciences, up from 2.15% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.06% in Q1 2020 to a low of 2.15% in Q2 2020.
  • A 4-year average of 0.66% and a median of 0.5% in 2017 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 47bps in 2020; the steepest drop was -190bps in 2020.
  • Forte Biosciences' Return on Assets stood at 0.4% in 2017, then dropped by -26bps to 0.5% in 2018, then rose by 23bps to 0.39% in 2019, then plummeted by -436bps to 2.08% in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Return on Assets are 2.08% (Q3 2020), 2.15% (Q2 2020), and 0.06% (Q1 2020).